PlainRecalls
FDA Drug Low Class III Terminated

Zoledronic Acid Injection 5 mg/100 mL (0.05 mg/mL), Solution for Intravenous Infusion, Sterile Solution, 100 mL Single - Dose Vial per Carton, Rx Only, Distributed by: Breckenridge Pharmaceutical, Inc., Boca Raton, FL 33487, Manufactured by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 51991-064-98.

Reported: March 4, 2020 Initiated: February 24, 2020 #D-1063-2020

Product Description

Zoledronic Acid Injection 5 mg/100 mL (0.05 mg/mL), Solution for Intravenous Infusion, Sterile Solution, 100 mL Single - Dose Vial per Carton, Rx Only, Distributed by: Breckenridge Pharmaceutical, Inc., Boca Raton, FL 33487, Manufactured by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 51991-064-98.

Reason for Recall

Failed Impurities/Degradation Specifications: Out-of-specification results obtained for impurities during stability testing.

Details

Units Affected
900 Vials
Distribution
Nationwide in the U.S.
Location
Berlin, CT

Frequently Asked Questions

What product was recalled?
Zoledronic Acid Injection 5 mg/100 mL (0.05 mg/mL), Solution for Intravenous Infusion, Sterile Solution, 100 mL Single - Dose Vial per Carton, Rx Only, Distributed by: Breckenridge Pharmaceutical, Inc., Boca Raton, FL 33487, Manufactured by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 51991-064-98.. Recalled by Breckenridge Pharmaceutical, Inc. Units affected: 900 Vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for impurities during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 4, 2020. Severity: Low. Recall number: D-1063-2020.